Navigation Links
Mutations can spur dangerous identity crisis in cells
Date:7/1/2011

As our bodies first form, developing cells are a lot like children put on the school bus with their names and addresses pinned to their shirts.

The notes identify one as a future heart cell, another as a liver cell, a third as a neuron. And that's what they each grow up to be.

But once those cells reach adulthood, changes to those original marching orders caused by aging, disease and other stressors like smoking can precipitate a kind of identity crisis, researchers at the University of Michigan Health System have found.

The cells start to forget things like which genes are supposed to be turned on and which turned off. This can lead to significant changes in their ability to function.

While microscopic, these changes can still have profound impacts on living beings. When this type of mutation was purposefully introduced into the heart muscle cells of mice, the normal functioning of the heart's electrical systems were disturbed, at times leading to dangerous arrhythmia, a new U-M study shows.

The results, published in the July issue of the Journal of Clinical Investigation, bring us one step closer to developing treatments for issues associated with aging or chronic diseases in which cells lose their ability to maintain a stable pattern of gene expression, says senior study author Gregory R. Dressler, Ph.D., collegiate professor of pathology research at the U-M Medical School.

"We're excited about this research because it suggests that these mutations can be the cause of disease as well as the result," says lead author Adam B. Stein, M.D., an assistant professor of cardiology at U-M.

Stein, Dressler and their colleagues are working in a relatively new area of research known as "epigenetics." It's well known that human beings pass a life code, bound up in the double helix of our DNA, from one generation to the next. What's less well understood is that they also transmit sets of instructions written in proteins and enzymes that tell each cell of the body which genes should be expressed, that is, which should be turned on and which turned off, Dressler says. (Epigenetic means, basically, a trait that is inherited but not encoded directly in the DNA.)

Early on, when all the cells in an embryo are an undifferentiated mass of stem cells, these instructions lay out the master plan. Like children groomed for the Olympic greatness, their destinies are spelled out for them: nerve, muscle, bone.

"What scientists didn't know was whether those instructions, once in place, must be maintained after a cell reaches maturity," Dressler explains. "We wanted to find out what happens when you remove some of the imprinting machinery that tells the heart cell that it's a heart cell."

The researchers found that those instructions matter quite a bit.

"What we found was that it's important for the body to keep telling the heart cell, 'You're a heart cell, you're a heart cell,' " says Dressler, who notes the research was the first time this mechanism has been studied in a living mammal. "When you knock out a piece of those instructions, the heart cell starts to forget who it is. These changes start off small, but over time they can have big effects on the organism."

Moreover, although they can be caused by environmental factors, negative changes like those that led to arrhythmia in the mice could potentially be passed down through the generations.

"The idea that cell state is a stable phenomenon is what's being challenged here," says Dressler. "We believe these findings could eventually lead to drug treatments to fight this type of cell destabilization."


'/>"/>

Contact: Ian Demsky
idemsky@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related biology news :

1. Evolutionary kings of the hill use good, bad and ugly mutations to speed ahead of competition
2. Scientists develop method to determine order of mutations that lead to cancer
3. Women with BRCA mutations can take hormone-replacement therapy safely after ovary removal
4. UMMS researchers develop new technology to screen and analyze genetic mutations
5. Researchers link gene mutations to Ebsteins anomaly
6. Drug may treat cystic fibrosis, other diseases caused by nonsense mutations, UAB researcher says
7. Scripps Research scientists reveal how genetic mutations may cause type 1 diabetes
8. Supplement blocks the initiation of breast cell mutations by estrogens
9. Penn biologists explain how organisms can tolerate mutations, yet adapt to environmental change
10. Mutations in different cells cooperate to set the stage for cancer
11. Study of huge numbers of genetic mutations point to oxidative stress as underlying cause
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... Feb. 2, 2016  Based on its recent ... Sullivan recognizes US-based Intelligent Retinal Imaging Systems (IRIS) ... Award for New Product Innovation. IRIS, a prominent ... North America , is poised to set ... diabetic retinopathy market. The IRIS technology presents superior ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of ... ended December 31, 2015. --> ... increased 2 percent compared to the comparable quarter last year to ... was $35.0 million, or $0.93 per diluted share. ... first quarter of fiscal 2016 grew 9 percent over the prior ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... , February 4, 2016 - New FDA action ... - New FDA action date of July 22, ... July 22, 2016   - ... in the past decade indicated for the treatment of signs and symptoms of ... has the potential to be the only product approved in the U.S. in ...
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... to be held February 8-9, 2016, at the Waldorf ... Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ContraVir, ...
(Date:2/4/2016)... 2016 Strasbourg, France , ... --> Strasbourg, France , to the US ... is pleased to announce that it acted as an advisor ... in Strasbourg, France , to the US ... --> Transgene (Euronext: TNG), a member of ...
Breaking Biology Technology: